Login/Sign Up
₹53846.94*
MRP ₹65667
18% off
₹55816.95*
MRP ₹65667
15% CB
₹9850.05 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Online payment accepted
Whats That
About Bonspri Solution for Injection
Bonspri Solution for Injection is an anti-cancer medicine used in the treatment of cancer. The intravenous route of this medicine is used in combination with chlorambucil for the treatment of CLL in patients for whom fludarabine-based therapy is considered inappropriate and as an extended treatment in patients who have a partial response after at least two lines of therapy. Chronic lymphocytic leukaemia is a cancer that occurs in the bone marrow and blood. The subcutaneous route of the medicine is used in treating relapsing forms of multiple sclerosis. It is a condition in which the immune system attacks the protective covering of the nerves called myelin.
Bonspri Solution for Injection contains Ofatumumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.
Bonspri Solution for Injection may cause certain side effects, such as nausea, vomiting, diarrhoea, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Bonspri Solution for Injection. Hence, do not self-administer.
While taking Bonspri Solution for Injection if you experience any allergic reaction, inform your doctor. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Bonspri Solution for Injection is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant beforehand. Breastfeeding mothers should avoid taking Bonspri Solution for Injection.
Uses of Bonspri Solution for Injection
Directions for Use
Medicinal Benefits
Bonspri Solution for Injection contains Ofatumumab, which belongs to the class of CD20-directed cytolytic antibodies. It is used in the treatment of chronic lymphocytic leukaemia. This medicine works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
Storage
Drug Warnings
Bonspri Solution for Injection should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Bonspri Solution for Injection may cause remission of active infections, severe skin reactions, tumour lysis syndrome (tumour cells release their contents into the bloodstream), hepatitis B virus reactivation, progressive multifocal leukoencephalopathy, and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Bonspri Solution for Injection may cause fetal B-cell depletion in infants. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Bonspri Solution for Injection is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
We provide you with authentic, trustworthy and relevant information
Drug-Diseases Interactions
Login/Sign Up
Bonspri Solution for Injection contains Ofatumumab, which works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells
Bonspri Solution for Injection may cause reactivation of serious infections, tumour lysis syndrome, hepatitis B virus reactivation, progressive multifocal leukoencephalopathy, and anaphylactic reactions in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Special Advise
Disease/Condition Glossary
Chronic Lymphocytic Leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Multiple sclerosis: Multiple sclerosis is a condition that affects the brain and spinal cord. The immune system attacks the protective covering of the nerves (myelin) and causes disrupted communication between the brain and body due to nerve damage. This causes symptoms such as problems with sensation, balance, vision, pain, impaired coordination, and fatigue.
Have a query?